Amgen Gets FDA Nod for Arthritis Drug Dosage

10/20/03 - 06:24 PM EDT

TSC Staff

Amgen(AMGN Quote - Cramer on AMGN - Stock Picks) and Wyeth Pharmaceuticals said Monday that the Food and Drug Administration has approved a once-weekly dosage of the arthritis drug Enbrel.

Enbrel is approved to treat moderate to severe active rheumatoid arthritis in patients with psoriatic arthritis and active ankylosing spondylitis, the company said.

Wyeth Pharmaceuticals is a division of Wyeth(WYE Quote - Cramer on WYE - Stock Picks).

Your Recent Quotes: Quote Up0 | Quote Down0
Dow S&P 500 NASDAQ
Oil*
Gold
10 Yr
0.00%
%
%
%
Data delayed 20 min
Sign up for our FREE newsletters now. See All

  • Cramer's Daily Booyah!
  • Before the Bell

Premium Stock Ideas
Access Action Alerts Plus to find out Cramer’s latest picks now!

Premium Services